ocular gene therapy
ocular gene therapy
Unlocking the Secrets of LNPs: Nano-Flow Cytometry Reveals All
📢 Comprehensive LNP Characterization from Cargo to Target Modification Using Nano-Flow Cytometry explores innovative techniques for analyzing lipid nanoparticles. 🔬🚀💊🔍✨
RevIT AAV: Transforming Gene Therapy Production Efficiency
🔍Discover RevIT AAV: A game-changing enhancer for gene therapy production, increasing efficiency by 2-4X. 🧬🔬🧪
MilliporeSigma Acquires Mirus Bio for $600 Million Expanding in Gene Therapy Market
MilliporeSigma 💪 powers up with $600M acquisition of Mirus Bio! 📆 Closing in Q3 2024. 😮 CellAndGeneTherapy BiotechNews
Revolutionary Company Solves Manufacturing Failures for Gene Therapy
📢 Introducing Bespark*bio: Tackling manufacturing failures in gene therapy to bring life-saving treatments to the market! 🏭💡💉
CEO of Généthon Reveals Future of Gene Therapy
🔍 Frédéric Revah, CEO of Généthon, reflects on the past, present, and future of the organization in an interview. 🧬 Généthon was created in 1990 with a focus on gene therapy research for rare genetic diseases. 💡 Revah discusses the challenges of financing development for rare diseases and the need for equity in distribution. 🏭 Généthon is working on improving bioprocessing and reducing the cost of production for gene therapies. 🤝 The organization collaborates with partners in various fields to advance their research. ⚙️ Exciting developments include producing AAV in plants and using artificial intelligence to optimize bioreactors. ❌ The industry faces challenges such as improving the full-to-empty ratio of virus capsids. ❗️ Revah comments on the Pfizer incident and assures that Généthon is closely monitoring safety in their own clinical trial.
Revolutionary Mass Photometry Boosts Gene Therapy Quality
🌟✨ Mass photometry is a game-changer for gene therapy companies, providing accurate assessments without labeling or long run times. 🧬💡
Revolutionary Alliance Launches AI-Driven Eye Therapy
👀 Three companies join forces to develop gene therapy for eye diseases, using AI and machine learning algorithms. 🧬👁️🔬
Revolutionary Automation System Cuts Cell and Gene Therapy Costs by 70
🤖 Vendor-agnostic automation system for cell and gene therapy manufacturing reduces errors and lowers costs.💡
Revolutionary Standardized Viral Vector Manufacturing for Gene Therapy
📰 AGC Biologics offers standardized viral vector manufacturing, covering the entire process from transfection to purification. 🔬💡🌐
Gene Therapy Revolution: The Power of ssDNA
🌟 The Emerging Role of ssDNA in Gene Therapy 🌟 Discover how single-stranded DNA is revolutionizing gene therapy, democratizing treatments and expanding accessibility. 🧪🔬✨
